E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/19/2022 in the Prospect News High Yield Daily.

New Issue: US Acute Care Solutions prices $225 million tap of 6 3/8% notes due 2026 at 101.5

By Paul A. Harris

Portland, Ore., Jan. 19 – US Acute Care Solutions, LLC priced a $225 million add-on to its 6 3/8% senior secured notes due March 1, 2026 (B2/B-) at 101.5 to yield 5.831% in a Wednesday drive-by, according to market sources.

The issue price came at the rich end of the 101 to 101.5 price talk. Initial guidance was 100 to 101.

The deal was heard to be two-times oversubscribed at 1 p.m. ET on Wednesday, a trader said.

Barclays was the left bookrunner. Apollo Global Securities LLC and Deutsche Bank Securities Inc. were also bookrunners.

The Canton, Ohio-based physician-owned emergency medicine, hospital and observation services provider plans to use the proceeds plus balance sheet cash and incremental preferred equity to fund the acquisition of Alteon Health.

The new add-on notes will be initially issued as temporary notes with substantially the same terms and conditions as the existing 6 3/8% secured notes due 2026. The temporary notes will be subject to a special mandatory redemption if the Alteon acquisition does not close. As soon as reasonably practicable after the closing of the acquisition the temporary notes will be exchanged into fungible add-ons to the existing 6 3/8% secured notes due 2026.

Issuer:US Acute Care Solutions, LLC
Amount:$225 million
Issue:Add-on to senior secured notes
Maturity:March 1, 2026
Bookrunners:Barclays (bill and deliver), Apollo Global Securities LLC and Deutsche Bank Securities Inc.
Coupon:6 3/8%
Price:101.5
Yield to maturity:5.831%
Spread:430 bps
First call:March 1, 2023 at 103.188
Trade date:Jan. 19
Settlement date:Feb. 1
Ratings:Moody's: B2
S&P: B-
Distribution:Rule 144A and Regulation S for life
Price talk:101 to 101.5
Marketing:Drive-by
Original issue:$375 million priced in February 2021
Previous add-on:$125 million priced in August 2021

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.